Comparative efficacy and safety of oral Chinese patent medicines combined with conventional therapy for coronary heart disease complicated by diabetes: a systematic review and network meta-analysis - Scorecard - MDSpire

Comparative efficacy and safety of oral Chinese patent medicines combined with conventional therapy for coronary heart disease complicated by diabetes: a systematic review and network meta-analysis

  • By

  • Dan Han

  • Bo-yi Wang

  • Xin-tian Yu

  • Chong-chai Li

  • Bo Liu

  • Zhan-ze Ma

  • April 30, 2026

  • 0 min

Share

Clinical Scorecard: Efficacy and Safety Comparison of Oral Chinese Patent Medicines with Standard Treatment for Coronary Heart Disease in Patients with Diabetes: A Systematic Review and Network Meta-Analysis

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care SettingSpecify types of clinical settings (e.g., hospitals, outpatient clinics).

Key Highlights

  • add

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • I
      • n
      • c
      • l
      • u
      • d
      • e
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • p
      • a
      • r
      • a
      • m
      • e
      • t
      • e
      • r
      • s
      • a
      • n
      • d
      • s
      • u
      • g
      • g
      • e
      • s
      • t
      • e
      • d
      • f
      • r
      • e
      • q
      • u
      • e
      • n
      • c
      • y
      • f
      • o
      • r
      • m
      • o
      • n
      • i
      • t
      • o
      • r
      • i
      • n
      • g
      • .

      Risks

        Patient & Prescribing Data

        Patients with coronary heart disease and diabetes mellitus.

        OCPMs can enhance the efficacy of conventional therapies by addressing multiple pathological processes.

        Clinical Best Practices

        • add

        References

        Original Source(s)

        Related Content